Takeda Pharmaceutical Cash Flow Statement
View: Annual | Quarterly
| Mar 08 | Mar 07+ | Dec 06+ | |
|---|---|---|---|
| Net Operating Cash Flow | 2,945.7 | 1,775.5 | -- |
| Net Investing Cash Flow | 1,024.7 | 987.5 | -- |
| Net Financing Cash Flow | (2,639.4) | (2,680.5) | -- |
| Net Change in Cash | (347.0) | 182.1 | -- |
| Depreciation & Amortization | 319.1 | 244.5 | -- |
| Capital Expenditures | (328.5) | (247.3) | -- |
| Cash Dividends Paid | (1,300.8) | (837.9) | -- |
© 2009 Morningstar, Inc. Financial Data provided by
